世界のテストステロン補充療法市場2022-2029:製品別(注射剤、外用剤、その他)、地域別

【英語タイトル】Global Testosterone Replacement Therapy Market Size study & Forecast, by Product (Injectables, Topicals, Others) and Regional Analysis, 2022-2029

Bizwit Research & Consultingが出版した調査資料(BZW22DC053)・商品コード:BZW22DC053
・発行会社(調査会社):Bizwit Research & Consulting
・発行日:2022年10月8日
・ページ数:約200
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:アメリカ、カナダ、イギリス、ドイツ、フランス、スペイン、イタリア、中国、インド、日本、オーストラリア、韓国、ブラジル、メキシコ、中東
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用、印刷不可)USD4,950 ⇒換算¥732,600見積依頼/購入/質問フォーム
Enterprisewide(同一法人内共有可)USD6,250 ⇒換算¥925,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

Bizwit Research社発行の本調査レポートによると、2021年におよそXX億ドルであった世界のテストステロン補充療法市場規模が、2022年から2029年の間にXX%以上成長すると予測されています。本レポートは、テストステロン補充療法の世界市場を対象とし、エグゼクティブサマリー、市場定義・範囲、市場動向、産業分析、リスク分析(新型コロナウイルス感染症の影響)、製品別(注射剤、外用剤、その他)分析、地域別(北米、ヨーロッパ、アジア太平洋、中南米、その他地域)分析、競争分析、調査プロセスなど、多面的な分析結果をまとめたものです。なお、参入企業情報として、AbbVie Inc、Endo Pharmaceuticals Inc、Pfizer, Inc、Eli Lilly and Company、Bayer AG、Teva Pharmaceutical Industries Ltd、Ferring Pharmaceuticals、Acerus Pharmaceuticals Corporation 、Mylan N.V、Perrigo Company Plcなどが含まれております。
・エグゼクティブサマリー
・市場定義・範囲
・市場動向
・産業分析
・リスク分析(新型コロナウイルス感染症の影響)

・世界のテストステロン補充療法市場規模:製品別
- 注射剤の市場規模
- 外用剤の市場規模
- その他製品の市場規模

・世界のテストステロン補充療法市場規模:地域別
- 北米のテストステロン補充療法市場規模
- ヨーロッパのテストステロン補充療法市場規模
- アジア太平洋のテストステロン補充療法市場規模
- 中南米のテストステロン補充療法市場規模
- その他地域のテストステロン補充療法市場規模

・競争分析
・調査プロセス

Global Testosterone Replacement Therapy Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029.
The distribution of testosterone during testosterone replacement treatment may take the form of lotions, injections, patches, gums/buccal adhesives, gels, or implants. A key male hormone called testosterone is in charge of enhancing spermatogenesis, male sexual traits, and reproduction. The prevalence of testosterone insufficiency is anticipated to rise as a result of the growing older population, unhealthy lifestyles, and disease load, which will accelerate the expansion of the market for testosterone replacement therapy over the forecasted period. Major driving factors driving the growth of the market over the forecasted period are growing prevalence of testosterone deficiency and growing number of geriatric populations.

The prevalence of testosterone deficiency in older men over 60 years of age increased by 21.67%, according to a December 2021 article in the Indian Journal of Endocrinology and Metabolism titled “Prevalence of Testosterone Deficiency in Elderly Male and its Association with Frailty and Mobility at a Tertiary Care Centre.” Men’s androgen levels gradually decline as they age. A need for treatment rather than testosterone is created by such testosterone overproduction, which propels market expansion. In the anticipated timeframe, market share will increase as a result of new product introductions. For instance, the AB generic version of AndroGel 1.62%, Testosterone Gel 1.62% Metered Dose Pump (20.25mg / 1.25g pump actuation), was developed by Xiromed LLC in August 2020. It is an alternate treatment for male diseases linked to persistent low testosterone or testosterone depletion. The negative consequences of testosterone replacement therapy and tight guidelines for product approval, however, will limit market expansion.

The key regions considered for the Global Testosterone Replacement Therapy Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America region is estimated to hold dominant position in the worldwide testosterone replacement therapy market over the forecast period, owing to rising number of product launches and approvals connected with androgen replacement therapy by regulatory agencies. For instance, Innovus Pharmaceuticals, Inc., a pharmaceutical firm in commercial development, got approval from Health Canada in February 2019 for its BH Testosterone Booster pills, which are designed to maintain testosterone levels and production in adult males. Additionally, the market for androgen replacement treatment is anticipated to rise significantly in Asia Pacific over the course of the projected period due to an increase in agreements by market participants. For instance, in August 2020, the pharmaceutical technology company Antares Pharma, Inc. and Lunatus Global Medical Supplies (‘Lunatus’) signed an exclusive distribution agreement for the distribution and marketing of XYOSTED, a testosterone enanthate injection, in Saudi Arabia and the United Arab Emirates (UAE).

Major market players included in this report are:
AbbVie Inc
Endo Pharmaceuticals Inc
Pfizer, Inc
Eli Lilly and Company
Bayer AG
Teva Pharmaceutical Industries Ltd
Ferring Pharmaceuticals
Acerus Pharmaceuticals Corporation
Mylan N.V
Perrigo Company Plc

Recent Developments in the Market:
 KYZATREX was approved by the US Food and Drug Administration for Marius Pharmaceuticals in August 2022. (Testosterone undecanoate). KYZATREX is an oral testosterone replacement therapy (“TRT”) that is recommended for adult males with hypogonadism or other diseases linked to a lack of endogenous testosterone.
 The testosterone undecanoate (TLANDO), an oral treatment for testosterone replacement therapy, was approved by the US Food and Drug Administration (FDA) in March 2022.

Global Testosterone Replacement Therapy Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Product, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:
Injectables
Topicals
Others

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

❖ レポートの目次 ❖

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Testosterone Replacement Therapy Market, by Region, 2019-2029 (USD Billion)
1.2.2. Testosterone Replacement Therapy Market, by Product, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Testosterone Replacement Therapy Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Testosterone Replacement Therapy Market Dynamics
3.1. Testosterone Replacement Therapy Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Increasing prevalence of testosterone deficiency
3.1.1.2. Growing Geriatric Population
3.1.2. Market Challenges
3.1.2.1. Strict rules and regulations
3.1.3. Market Opportunities
3.1.3.1. Rising initiatives by the key market players
Chapter 4. Global Testosterone Replacement Therapy Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Investment Adoption Model
4.5. Analyst Recommendation & Conclusion
4.6. Top investment opportunity
4.7. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Testosterone Replacement Therapy Market, by Product
6.1. Market Snapshot
6.2. Global Testosterone Replacement Therapy Market by Product, Performance – Potential Analysis
6.3. Global Testosterone Replacement Therapy Market Estimates & Forecasts by Product, 2019-2029 (USD Billion)
6.4. Testosterone Replacement Therapy Market, Sub Segment Analysis
6.4.1. Injectables
6.4.2. Topicals
6.4.3. Others
Chapter 7. Global Testosterone Replacement Therapy Market, Regional Analysis
7.1. Testosterone Replacement Therapy Market, Regional Market Snapshot
7.2. North America Testosterone Replacement Therapy Market
7.2.1. U.S. Testosterone Replacement Therapy Market
7.2.1.1. Product breakdown estimates & forecasts, 2019-2029
7.2.2. Canada Testosterone Replacement Therapy Market
7.3. Europe Testosterone Replacement Therapy Market Snapshot
7.3.1. U.K. Testosterone Replacement Therapy Market
7.3.2. Germany Testosterone Replacement Therapy Market
7.3.3. France Testosterone Replacement Therapy Market
7.3.4. Spain Testosterone Replacement Therapy Market
7.3.5. Italy Testosterone Replacement Therapy Market
7.3.6. Rest of Europe Testosterone Replacement Therapy Market
7.4. Asia-Pacific Testosterone Replacement Therapy Market Snapshot
7.4.1. China Testosterone Replacement Therapy Market
7.4.2. India Testosterone Replacement Therapy Market
7.4.3. Japan Testosterone Replacement Therapy Market
7.4.4. Australia Testosterone Replacement Therapy Market
7.4.5. South Korea Testosterone Replacement Therapy Market
7.4.6. Rest of Asia Pacific Testosterone Replacement Therapy Market
7.5. Latin America Testosterone Replacement Therapy Market Snapshot
7.5.1. Brazil Testosterone Replacement Therapy Market
7.5.2. Mexico Testosterone Replacement Therapy Market
7.6. Rest of The World Testosterone Replacement Therapy Market

Chapter 8. Competitive Intelligence
8.1. Top Market Strategies
8.2. Company Profiles
8.2.1. AbbVie Inc
8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Product Summary
8.2.1.5. Recent Developments
8.2.2. Endo Pharmaceuticals Inc
8.2.3. Pfizer, Inc
8.2.4. Eli Lilly and Company
8.2.5. Bayer AG
8.2.6. Teva Pharmaceutical Industries Ltd
8.2.7. Ferring Pharmaceuticals
8.2.8. Acerus Pharmaceuticals Corporation
8.2.9. Mylan N.V
8.2.10. Perrigo Company Plc
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption



★調査レポート[世界のテストステロン補充療法市場2022-2029:製品別(注射剤、外用剤、その他)、地域別] (コード:BZW22DC053)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のテストステロン補充療法市場2022-2029:製品別(注射剤、外用剤、その他)、地域別]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆